Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

We compared serious early and late events experienced by 2726 bone marrow (BM) and 6768 peripheral blood stem cell (PBSC) donors who underwent collection of PBSC or BM between 2004 and 2009 as part of a prospective study through the National Marrow Donor Program. Standardized FDA definitions for ser...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pulsipher, Michael A., Chitphakdithai, Pintip, Logan, Brent R., Navarro, Willis H., Levine, John E., Miller, John P., Shaw, Bronwen E., O’Donnell, Paul V., Majhail, Navneet S., Confer, Dennis L.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2014
Sujets:
Transfusion Medicine
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4047500/
https://ncbi.nlm.nih.gov/pubmed/24735965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-12-542464
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires